MYCN and neuroblastoma: As a key oncogene driver in neuroblastoma, MYCN (N-Myc) is also a critical regulator of NEPC and SCLC (small cell lung cancer, a poorly differentiated neuroendocrine lung cancer) (21, 37, 71, 115).